The Valley Hospital, Inc.
Welcome,         Profile    Billing    Logout  
 9 Trials 
26 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mittal, Suneet
REACT-AF, NCT05836987: The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

Recruiting
3
5350
US
AFSW Guided DOAC, Apple Watch, Continuous DOAC therapy, Oral Anticoagulation therapy
Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI)
Atrial Fibrillation
07/29
07/29
PUFA, NCT00841451: Pulmonary Vein Isolation Outcomes With Fish Oils

No Longer Available
N/A
US
Lovaza (Fish Oils), Lovaza NDA021654, Omacor NDA021853
St. Luke's-Roosevelt Hospital Center, GlaxoSmithKline
Atrial Fibrillation
 
 
FROZEN-AF, NCT04133168: Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation

Completed
N/A
458
Europe, Canada, US, RoW
Boston Scientific Cardiac Cryoablation System
Boston Scientific Corporation
Paroxysmal Atrial Fibrillation
11/22
08/23
NCT04092166: Impact of a Structured Cardiac Rehabilitation Program on Cardiorespiratory Fitness in Patients With Atrial Fibrillation

Active, not recruiting
N/A
120
US
Stationary Bike
Valley Health System
Atrial Fibrillation
05/23
05/24
NCT05356546: TYRX™ Pocket Health Study

Completed
N/A
36
Europe, Canada, US
Study-required procedures include: tissue collection from device capsule, questionnaire collection, and photo collection
Medtronic Cardiac Rhythm and Heart Failure
Cardiac Disease, Healing Surgical Wounds
07/23
07/23
PEAKS, NCT05247320: Prospective Evaluation Analysis and Kinetics Registry

Completed
N/A
167
US
Sotalol Injection
University of Utah, AltaThera Pharmaceuticals, LLC
Atrial Arrhythmia
08/23
08/23
AVANT GUARD, NCT06096337: Pulsed Field Ablation (PFA) Vs Anti-Arrhythmic Drug (AAD) Therapy As a First Line Treatment for Persistent Atrial Fibrillation

Recruiting
N/A
520
Europe, Canada, US, RoW
FARAPULSE™ Pulsed Field Ablation (PFA) System, Anti-Arrhythmic Drug (AAD): Flecainide, Sotalol, Propafenone, Dofetilide, and Dronedarone
Boston Scientific Corporation
Persistent Atrial Fibrillation
12/25
12/27
NCT04061603: iCLAS™ for Persistent Atrial Fibrillation

Active, not recruiting
N/A
200
Europe, Canada, US
Adagio AF Cryoablation System (iCLAS™)
Adagio Medical
Persistent Atrial Fibrillation
08/23
08/24
NCT04091048: Optimize PRO Study

Active, not recruiting
N/A
800
Europe, Canada, US, RoW
Evolut™ PRO and Evolut™ PRO+ System (Evolut™ FX System for the addendum)
Medtronic Cardiovascular
Symptomatic Aortic Stenosis
12/23
12/24
NCT04600791: BATwire Implant Kit

Active, not recruiting
N/A
93
US
BATwire Implant Kit
CVRx, Inc.
Heart Failure
08/24
07/25
ADVANTAGE AF, NCT05443594: A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects with Persistent Atrial Fibrillation

Active, not recruiting
N/A
669
Europe, Canada, US
Phase 1: FARAPULSE Ablation System, Phase 2: FARAPULSE Ablation System
Boston Scientific Corporation
Persistent Atrial Fibrillation
03/25
03/25
NCT03970343: Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy

Recruiting
N/A
620
US
OPTIMIZER Smart System
Impulse Dynamics
Heart Failure
03/26
03/26
rēST Study, NCT03884660: Remedē System Therapy Study

Recruiting
N/A
500
Europe, US
remede System
Respicardia, Inc.
Central Sleep Apnea
06/27
06/32
NCT04502316: Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)

Recruiting
N/A
5000
US
Barostim™ System
CVRx, Inc.
Heart Failure
06/28
06/28
Sarrafi, Shahram
REACT-AF, NCT05836987: The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

Recruiting
3
5350
US
AFSW Guided DOAC, Apple Watch, Continuous DOAC therapy, Oral Anticoagulation therapy
Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI)
Atrial Fibrillation
07/29
07/29
HIS-CRT, NCT05265520: His-Bundle Corrective Pacing in Heart Failure

Recruiting
N/A
120
US
His-CRT implantation, BIV-CRT implantation
University of Rochester, National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)
Right Bundle-Branch Block, Heart Failure, His-bundle Pacing, Cardiac Resynchronization Therapy
01/26
07/27
rēST Study, NCT03884660: Remedē System Therapy Study

Recruiting
N/A
500
Europe, US
remede System
Respicardia, Inc.
Central Sleep Apnea
06/27
06/32
NCT04502316: Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)

Recruiting
N/A
5000
US
Barostim™ System
CVRx, Inc.
Heart Failure
06/28
06/28
NCT05650658: Left vs Left Randomized Clinical Trial

Recruiting
N/A
2136
US
His/LBBP, BiVP
Baylor College of Medicine, Patient-Centered Outcomes Research Institute, University of Utah, Virginia Commonwealth University, Rush University, East Carolina University
Heart Failure, Heart Failure With Reduced Ejection Fraction, AV Block, LBBB, RBBB, Intraventricular Conduction Delay, Pacing-Induced Cardiomyopathy
06/29
06/29
Sayles, Kathleen
REACT-AF, NCT05836987: The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

Recruiting
3
5350
US
AFSW Guided DOAC, Apple Watch, Continuous DOAC therapy, Oral Anticoagulation therapy
Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI)
Atrial Fibrillation
07/29
07/29
NCT05693090: Tipifarnib and Osimertinib in EGFR-mutated Non-Small Cell Lung Cancer

Withdrawn
1
50
US
Tipifarnib, Osimertinib
Kura Oncology, Inc.
NSCLC
07/27
07/27
NCT03811795: Cryoballoon vs. Rhythmia Guided Ablation for Recurrent AFib

Recruiting
N/A
50
US
ECG monitoring with a Kardia Mobile monitor
Valley Health System
Atrial Fibrillation
11/22
11/23
Pichardo, Vianca
REACT-AF, NCT05836987: The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

Recruiting
3
5350
US
AFSW Guided DOAC, Apple Watch, Continuous DOAC therapy, Oral Anticoagulation therapy
Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI)
Atrial Fibrillation
07/29
07/29
rēST Study, NCT03884660: Remedē System Therapy Study

Recruiting
N/A
500
Europe, US
remede System
Respicardia, Inc.
Central Sleep Apnea
06/27
06/32
Volgman, Annabelle
REACT-AF, NCT05836987: The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

Recruiting
3
5350
US
AFSW Guided DOAC, Apple Watch, Continuous DOAC therapy, Oral Anticoagulation therapy
Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI)
Atrial Fibrillation
07/29
07/29
Dabbas, Jood
REACT-AF, NCT05836987: The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

Recruiting
3
5350
US
AFSW Guided DOAC, Apple Watch, Continuous DOAC therapy, Oral Anticoagulation therapy
Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI)
Atrial Fibrillation
07/29
07/29

Download Options